microRNA-135a-5p regulates NOD-like receptor family pyrin domain containing 3 inflammasome-mediated hypertensive cardiac inflammation and fibrosis via thioredoxin-interacting protein
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
microRNA-135a-5p regulates NOD-like receptor family pyrin domain containing 3 inflammasome-mediated hypertensive cardiac inflammation and fibrosis via thioredoxin-interacting protein
Authors
Keywords
-
Journal
Bioengineered
Volume 13, Issue 3, Pages 4658-4673
Publisher
Informa UK Limited
Online
2022-02-12
DOI
10.1080/21655979.2021.2024956
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging Role of the Inflammasome and Pyroptosis in Hypertension
- (2021) Carmen De Miguel et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- microRNA-130a-5p suppresses myocardial ischemia reperfusion injury by downregulating the HMGB2/NF-κB axis
- (2021) Yong Li et al. BMC Cardiovascular Disorders
- Scoparone alleviates Ang II‐induced pathological myocardial hypertrophy in mice by inhibiting oxidative stress
- (2021) Linmao Lyu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Silencing of OIP5-AS1 Protects Endothelial Cells From ox-LDL-Triggered Injury by Regulating KLF5 Expression via Sponging miR-135a-5p
- (2021) Minghu Zhao et al. Frontiers in Cardiovascular Medicine
- FAM134B-mediated endoplasmic reticulum autophagy protects against sepsis myocardial injury in mice
- (2021) Tong Li et al. Aging-US
- Integrating Measures of Myocardial Fibrosis in the Transition from Hypertensive Heart Disease to Heart Failure
- (2021) R. Brandon Stacey et al. CURRENT HYPERTENSION REPORTS
- Extracellular vesicles derived from M2 microglia reduce ischemic brain injury through microRNA-135a-5p/TXNIP/NLRP3 axis
- (2021) Yue Liu et al. LABORATORY INVESTIGATION
- MiR-135a Protects against Myocardial Injury by Targeting TLR4
- (2021) Hui Feng et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Schisandrin B Attenuates Airway Inflammation and Airway Remodeling in Asthma by Inhibiting NLRP3 Inflammasome Activation and Reducing Pyroptosis
- (2021) Xiufeng Chen et al. INFLAMMATION
- Protective effect of dimethyl itaconate against fibroblast–myofibroblast differentiation during pulmonary fibrosis by inhibiting TXNIP
- (2021) Yong‐Yue Han et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Hsp22 ameliorates lipopolysaccharide-induced myocardial injury by inhibiting inflammation, oxidative stress, and apoptosis
- (2021) Yun Yu et al. Bioengineered
- Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis
- (2020) Anita A. Pinar et al. PHARMACOLOGY & THERAPEUTICS
- The association between microRNA-21 and hypertension-induced cardiac remodeling
- (2020) Ken Watanabe et al. PLoS One
- Obesity, Hypertension, and Cardiac Dysfunction
- (2020) Alan J. Mouton et al. CIRCULATION RESEARCH
- Lycorine ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3 inflammasome activation and pyroptosis
- (2020) Qing Liang et al. PHARMACOLOGICAL RESEARCH
- Rivaroxaban ameliorates angiotensin II-induced cardiac remodeling by attenuating TXNIP/Trx2 interaction in KKAy mice
- (2020) Yamin Rao et al. THROMBOSIS RESEARCH
- The Circular RNA CDR1as Regulates the Proliferation and Apoptosis of Human Cardiomyocytes Through the miR-135a/HMOX1 and miR-135b/HMOX1 Axes
- (2020) Cheng Chen et al. Genetic Testing and Molecular Biomarkers
- FOXF1 ameliorates angiotensin II-induced cardiac fibrosis in cardiac fibroblasts through inhibiting the TGF-β1/Smad3 signaling pathway
- (2020) Daoxin Jin et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- miR-135a Alleviates Silica-Induced Pulmonary Fibrosis by Targeting NF-κB/Inflammatory Signaling Pathway
- (2020) Bin Xie et al. MEDIATORS OF INFLAMMATION
- Treatment of Hypertensive Heart Disease by Targeting Smad3 Signaling in Mice
- (2020) Jinxiu Meng et al. Molecular Therapy-Methods & Clinical Development
- Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure
- (2020) Anis Hanna et al. CARDIOVASCULAR DRUGS AND THERAPY
- Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
- (2020) Mark Sweeney et al. EMBO Molecular Medicine
- Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension
- (2020) Daniel N. Meijles et al. HYPERTENSION
- TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation
- (2020) Hee-Seon Park et al. Autophagy
- Circular RNA Arhgap12 modulates doxorubicin-induced cardiotoxicity by sponging miR-135a-5p
- (2020) Xuejun Wang et al. LIFE SCIENCES
- The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy
- (2020) Zhenzhen Li et al. Acta Pharmaceutica Sinica B
- microRNA-135a protects against myocardial ischemia-reperfusion injury in rats by targeting protein tyrosine phosphatase 1B
- (2019) Sheng Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Myocardial Scar and Fibrosis
- (2019) Erik B. Schelbert Heart Failure Clinics
- Pulmonary Hypertension Due to Left Heart Disease: an Update
- (2019) Mandar A. Aras et al. Current Cardiology Reports
- Pulmonary hypertension and valvular heart disease
- (2019) T. Tichelbäcker et al. HERZ
- Astragaloside IV inhibits cardiac fibrosis via miR-135a-TRPM7-TGF-β/Smads pathway
- (2019) Yanchun Wei et al. JOURNAL OF ETHNOPHARMACOLOGY
- The SGK1 inhibitor EMD638683, prevents Angiotensin II–induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation
- (2018) Wenqiang Gan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- MicroRNA-135a inhibits cardiac fibrosis induced by isoproterenol via TRPM7 channel
- (2018) Yan Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- IRE1α inhibition decreased TXNIP/NLRP3 inflammasome activation through miR-17-5p after neonatal hypoxic–ischemic brain injury in rats
- (2018) Di Chen et al. Journal of Neuroinflammation
- NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice
- (2018) Ming Wu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload–Induced Heart FailureNovelty and Significance
- (2017) Robin Verjans et al. HYPERTENSION
- Hypertension, left ventricular hypertrophy, and sudden cardiac death
- (2017) Mohammad Shenasa et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
- (2017) Auvro R. Mridha et al. JOURNAL OF HEPATOLOGY
- NLRP3 inflammasome and its inhibitors: a review
- (2015) Bo-Zong Shao et al. Frontiers in Pharmacology
- Myocardial remodeling in hypertension
- (2014) W Nadruz JOURNAL OF HUMAN HYPERTENSION
- starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data
- (2013) Jun-Hao Li et al. NUCLEIC ACIDS RESEARCH
- Thioredoxin interacting protein genetic variation is associated with diabetes and hypertension in the Brazilian general population
- (2011) Noely E. Ferreira et al. ATHEROSCLEROSIS
- Smad3 Mediates Cardiac Inflammation and Fibrosis in Angiotensin II–Induced Hypertensive Cardiac Remodeling
- (2010) Xiao R. Huang et al. HYPERTENSION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now